.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Farmers Insurance
Mallinckrodt
Queensland Health
Citi
AstraZeneca
Express Scripts
Cantor Fitzgerald
Moodys

Generated: July 22, 2017

DrugPatentWatch Database Preview

NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE Drug Profile

« Back to Dashboard

What is the patent landscape for Neomycin Sulfate-dexamethasone Sodium Phosphate, and when can generic versions of Neomycin Sulfate-dexamethasone Sodium Phosphate launch?

Neomycin Sulfate-dexamethasone Sodium Phosphate is a drug marketed by Alcon Pharms Ltd and Pharmafair and is included in two NDAs.

The generic ingredient in NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.

Summary for Tradename: NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE

Patents:0
Applicants:2
NDAs:2
Clinical Trials: see list5,482
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062714-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe
Pharmafair
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062539-001Jan 10, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Dow
QuintilesIMS
Teva
Deloitte
McKinsey
AstraZeneca
Accenture
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot